Genes in panel
STRs in panel
Prev Next

Early onset or syndromic epilepsy

Gene: FAR1

Green List (high evidence)

FAR1 (fatty acyl-CoA reductase 1)
EnsemblGeneIds (GRCh38): ENSG00000197601
EnsemblGeneIds (GRCh37): ENSG00000197601
OMIM: 616107, Gene2Phenotype
FAR1 is in 11 panels

6 reviews

Eleanor Williams (Genomics England Curator)

The rating of this gene has been updated to green following NHS Genomic Medicine Service approval.
Created: 8 Feb 2023, 3:49 p.m. | Last Modified: 8 Feb 2023, 3:49 p.m.
Panel Version: 3.36

Helen Lord (Oxford Medical Genetics Laboratories)

Green List (high evidence)

PMID 33239752 - 12 patients with de novo FAR1 missense variants Arg480Cys/His/Leu - 8/12 seizures as part of phenotype.

PMID 25439727 - 2 unrelated families - family 1 2 sibs (consanguineous) with hom in frame deletion;family 2 individual compound het for missense and nonsense variant - all 3 had seizures reported as part of phenotype.
PMID 33586168 - child with consanguineous parents - hom nonsense variant - epileptic spasms reported as part of phenotype.
PMID 28454995 - hom missense variant reported - case 156 (Supp info) - diagnosis of peroxisomal fatty Acyl-CoA reductase I disorder but no clinical information included.

12 AD de novo cases 8/12 with epilepsy pheno - ok to classify as green
4 AR families 4/5 (3 families) epilepsy pheno, 1 no clinical info provided. ok to classify as green,
Created: 6 Jul 2022, 3:06 p.m. | Last Modified: 6 Jul 2022, 3:06 p.m.
Panel Version: 2.543

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
cataracts, spastic paraparesis and speech delay & peroxisomal fatty Acyl-CoA reductase I disorder

Publications

Arina Puzriakova (Genomics England Curator)

The mode of inheritance of this gene has been updated to 'BOTH monoallelic and biallelic, autosomal or pseudoautosomal' following NHS Genomic Medicine Service approval.
Created: 1 Feb 2023, 9:39 a.m. | Last Modified: 1 Feb 2023, 9:39 a.m.
Panel Version: 3.29
Comment on mode of inheritance: As only 2/4 families with biallelic variants in this gene presented with epilepsy, in 2019, the rating was set to Amber for this allelic requirement (no new related evidence since). However, there is now evidence supporting pathogenicity of monoallelic variants affecting the Arg480 residue, and the number of unrelated individuals with seizures (8) reaches the threshold for inclusion with the monoallelic MOI.

FAR1 will be flagged for GMS expert review to determine the most appropriate MOI and rating on this panel.
Created: 28 Jun 2021, 11:17 a.m. | Last Modified: 16 Mar 2022, 3:38 p.m.
Panel Version: 2.500
Associated with relevant phenotype in OMIM and has a 'confirmed' disease confidence rating for 'Severe intellectual disability, epilepsy, and cataracts' in Gene2Phenotype.

Both biallelic and monoallelic variants have been linked to disease; both supported by functional data but showing distinct biochemical phenotypes. Seizures are reported in 3/5 patients (4 families - 2 with same founder variant, neither of which had seizures) with biallelic variants (PMIDs: 25439727; 30561787) and in 8/12 patients with heterozygous de novo variants (PMID: 33239752)
Created: 28 Jun 2021, 11:02 a.m. | Last Modified: 28 Jun 2021, 11:02 a.m.
Panel Version: 2.377

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Peroxisomal fatty acyl-CoA reductase 1 disorder, OMIM:616154

Publications

Rebecca Foulger (Genomics England curator)

I don't know

As discussed with members of the GMS Neurology Specialist Test Group on the Webex call 22nd November 2019 for Clinical Indication R59 Early onset or syndromic epilepsy: Agreed that there is insufficient evidence to rate this gene Green. Demoted from Green to Amber.
Created: 25 Nov 2019, 8:49 p.m. | Last Modified: 25 Nov 2019, 8:50 p.m.
Panel Version: 1.439
Review and rating collated by Tracy Lester (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust, 2019_02_06) on behalf of Wessex and West Midlands GLH for GMS Neurology specialist test group, for Clinical Indication R59 'Early onset or syndromic epilepsy'. Review contributors: John Taylor and Helen Lord. Suggested gene rating: Amber.
Created: 6 Aug 2019, 8:38 p.m. | Last Modified: 6 Aug 2019, 8:38 p.m.
Panel Version: 1.189

Tracy Lester (Genetics laboratory, Oxford UK)

I don't know

AR peroxisomal fatty acyl-CoA reductase 1 disorder - onset in infancyof severely delayed psychomotor development, growth retardation with microcephaly and seizures. Buchert et al, 2014 -3 patients from 2 families with a severe disorder all had early-onset epilepsy. Bialleleic mutations identified in FAR1 (hom indel in consang family and compound het for a missense and a nonsense) and in vitro expression studies showed that all the mutations resulted in a complete loss of enzyme activity.
Created: 6 Aug 2019, 8:31 p.m. | Last Modified: 6 Aug 2019, 8:31 p.m.
Panel Version: 1.188

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154

Publications

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Gene originally listed on the Intellectual disability panel V2.42.
Associated with relevant phenotypes in OMIM and as confirmed Gen2Phen gene. At least 3 variants reported in 2 unrelated cases, supportive functional studies provided for each variant (PMID 25439727).
Created: 10 Apr 2018, 9:02 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Peroxisomal fatty acyl-CoA reductase 1 disorder 616154

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Wessex and West Midlands GLH
  • NHS GMS
  • Expert Review
Phenotypes
  • Peroxisomal fatty acyl-CoA reductase 1 disorder, OMIM:616154
  • fatty acyl-CoA reductase 1 deficiency, MONDO:0014510
OMIM
616107
Clinvar variants
Variants in FAR1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

8 Feb 2023, Gel status: 3

Removed Tag, Removed Tag, Removed Tag

Eleanor Williams (Genomics England Curator)

Tag Q2_21_expert_review was removed from gene: FAR1. Tag Q2_21_MOI was removed from gene: FAR1. Tag Q3_22_NHS_review was removed from gene: FAR1.

8 Feb 2023, Gel status: 3

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: far1 has been classified as Green List (High Evidence).

1 Feb 2023, Gel status: 2

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene FAR1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

11 Aug 2022, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: FAR1 were changed from Peroxisomal fatty acyl-CoA reductase 1 disorder, OMIM:616154 to Peroxisomal fatty acyl-CoA reductase 1 disorder, OMIM:616154; fatty acyl-CoA reductase 1 deficiency, MONDO:0014510

11 Aug 2022, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q3_22_NHS_review tag was added to gene: FAR1.

28 Jun 2021, Gel status: 2

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: FAR1 was changed from BIALLELIC, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal

28 Jun 2021, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: FAR1 were set to 25439727

28 Jun 2021, Gel status: 2

Added Tag, Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q2_21_expert_review tag was added to gene: FAR1. Tag Q2_21_MOI tag was added to gene: FAR1.

13 Apr 2021, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: FAR1 were changed from Peroxisomal fatty acyl-CoA reductase 1 disorder 616154 to Peroxisomal fatty acyl-CoA reductase 1 disorder, OMIM:616154

25 Nov 2019, Gel status: 2

Entity classified by Genomics England curator

Rebecca Foulger (Genomics England curator)

Gene: far1 has been classified as Amber List (Moderate Evidence).

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source Wessex and West Midlands GLH was added to FAR1.

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source NHS GMS was added to FAR1.

11 Dec 2018, Gel status: 3

Panel promoted to version 1.0

Sarah Leigh (Genomics England Curator)

Sarah Leigh: Gene originally listed on the

10 Apr 2018, Gel status: 3

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

10 Apr 2018, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

FAR1 was added to Genetic Epilepsy Syndromes panel. Sources: Expert Review

10 Apr 2018, Gel status: 1

Created

Sarah Leigh (Genomics England Curator)

FAR1 was created by Sarah Leigh